Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > How the heck….
View:
Post by JohnnyCashMoney on Nov 10, 2022 8:29am

How the heck….

Do you enrol 8 patients in 3 month but expect 90 by Q1 of 2023? Crystal Balls? Overpromise and disappointment to come?????
Comment by JohnnyCashMoney on Nov 10, 2022 8:33am
42 patients in the next 4.5 months. Those other 2 sites better get moving.
Comment by mercedesman on Nov 10, 2022 11:54am
How the math works (AP please check it for me) To get to 90 how many need to be enrolled per site per month? First the assumptions needed from today's PR: "There are currently 14 Tigris sites onboarded and actively enrolling patients. The Company is nearing completion of onboarding an additional two sites with two more expected to be onboarded by the end of 2022." and " ...more  
Comment by Accountprince on Nov 10, 2022 12:11pm
MM - your math is always impeccable so I'm sure it's correct.  They did say the upcoming flu season - expected to be very pervasive - will provide the required cases in the trial sites.  And 42 isn't a big number in the context of 14 and then 18 sites.  Flu season will produce enough cases (look at Australia) and I expect GREED will capture them pronto for Tigris. More ...more  
Comment by mercedesman on Nov 10, 2022 12:50pm
I agree. The new Baxter deal was fuzzy before (highly redacted).   Now we add more fuzziness.  Exactly how, if at all, are tranche 2 and 3 impacted by the convertibel debt taken by Baxter? This speaks to short term finnacing and cash flow - arguably a material matter for most thoughtful investors. Apparently, whatever the change, it wasn't enough to dissuade insiders from ...more  
Comment by Accountprince on Nov 10, 2022 1:24pm
MM - perhaps they had to wait until all conditions were right.  We only know what they disclosed about the Baxter change (US$2.5 mill invested) - we don't know what other changes might have been made to the (redacted) deal.  Why disclose changes to elements that are secret anyway?  You'd have to reveal the original secret first for the change to be understandable.  ...more  
Comment by mercedesman on Nov 10, 2022 1:44pm
AP Right you are again. Why tell us that they changed something that they couldn't tell us about before.?  How does that make us any less confused? Perhaps the answer will be once again buried deep in the bowels of Sedar ? I also totally agree that it's notable that Baxter  has spent a lot of time prepping already....and continues to do so....   In anticipation of a ...more  
Comment by Quacker on Nov 10, 2022 3:01pm
Do you think Paradigm and the majority of insiders probably know the selling price to Baxter. If the case than let everyone know and see how the market handles the SP of the stock. Same with Dialco. We all thought it was Baxter who would buy, so why hide it now. Are you embarrassed on what you got.
Comment by Accountprince on Nov 10, 2022 11:10am
JCM - to answer how you reach 90 patients by Q1 of 2023 the answer is very simple...GREED.  Seto and Kellum need to get PMX FDA approved no later than June 29 2023 in order to each be granted 2,250,000 PSU shares of Spectral.  If you use the consensus here that's $9 million EACH at $4 Cdn a share.  They will move heaven and earth to EACH get this payday.  As of June 30 2023 ...more  
Comment by hmmmmmmmm on Nov 10, 2022 11:30am
Oct. 4th PR had Spectral at 44 patients. Today's PR states they are at 48.  4 enrolled in a month- with no COVID filled hospitals to blame. 4 is only half of Seto and Kellum's stated "worst case scenario" for enrollment. They were given a carrot of millions of options to motivate them.. Still they are failing to get anywhere close to the worst case that they set for ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities